QT-PINE SR 300: Unveiling Quetiapine Prolonged Release (300mg)

Quetiapine Prolonged Release (300mg) & QT-PINE SR 300

Quetiapine Prolonged Release, known by the brand name QT-PINE SR 300, represents a significant advancement in the treatment of psychiatric disorders. With its sustained-release formulation delivering 300mg of Quetiapine, QT-PINE SR 300 offers a convenient and effective solution for patients requiring long-term symptom management. This comprehensive guide delves into the uses, dosage guidelines, benefits, potential side effects, and other essential considerations associated with QT-PINE SR 300.

Understanding QT-PINE SR 300:

1. Sustained Release Formulation:

QT-PINE SR 300 features a prolonged-release formulation of Quetiapine, ensuring gradual and sustained delivery of the medication over an extended period. This sustained release profile allows for once-daily dosing, providing consistent symptom control and enhancing patient adherence compared to immediate-release formulations.

2. Therapeutic Uses:

QT-PINE SR 300 is primarily indicated for the treatment of schizophrenia and bipolar disorder. It is also used in the management of depressive episodes in bipolar disorder and as adjunctive therapy for major depressive disorder. Quetiapine, the active ingredient in QT-PINE SR 300, acts as an antagonist at multiple neurotransmitter receptors, including dopamine and serotonin receptors, to alleviate symptoms of psychosis and mood disorders.

3. Dosage Guidelines:

The recommended starting dose of QT-PINE SR 300 for schizophrenia is typically 50mg once daily, with gradual titration as tolerated to a maintenance dose of 300-800mg daily. For bipolar disorder, the initial dose may range from 50mg to 100mg once daily, with adjustments based on individual response. Dosage adjustments should be made under the supervision of a healthcare provider.

4. Benefits of Prolonged Release:

QT-PINE SR 300 offers several advantages over immediate-release formulations. The prolonged-release profile ensures steady blood levels of Quetiapine throughout the day, minimizing fluctuations and providing continuous symptom relief. This can result in improved tolerability and reduced risk of certain side effects associated with rapid changes in drug concentration.

5. Potential Side Effects:

Common side effects of QT-PINE SR 300 may include drowsiness, dizziness, dry mouth, and weight gain. Some patients may experience metabolic changes, such as elevated cholesterol or triglyceride levels. Rare but serious side effects include orthostatic hypotension, tardive dyskinesia, and neuroleptic malignant syndrome.

Conclusion:

In conclusion, QT-PINE SR 300 offers a convenient and effective treatment option for individuals with schizophrenia and bipolar disorder. Its prolonged-release formulation provides continuous symptom control and improved patient adherence compared to immediate-release formulations. However, like all medications, QT-PINE SR 300 carries potential risks and side effects that should be carefully considered and monitored. Patients should work closely with their healthcare provider to determine if QT-PINE SR 300 is the right treatment option for their psychiatric condition. 

Steris Healthcare Pvt Ltd, established in February 2018 by seasoned professionals in the pharmaceutical sector, operates under the name Sterispharma. Headquartered in Navi Mumbai, the company is certified by WHO, GMP, and ISO. Sterispharma is dedicated to providing high-quality medications at affordable prices across India, adhering to stringent WHO guidelines. They offer an online pharmacy platform for easy medicine purchases and home delivery. The company's mission is to deliver a diverse range of healthcare products catering to the varied needs of the medical community. From advanced treatments and rare condition medications to essential health supplies, Sterispharma aims to meet the extensive demands of the healthcare industry. Their product range covers numerous health fields, including Cardiology, Asthma, Respiratory issues, Nasal conditions, Diabetes, Endocrinology, Gastroenterology, Orthopedics, Anti-infectives/antibiotics, General Medicine, Urology, Neurology, Nephrology, Oncology, Gynecology, Pediatrics, Dental care, and Dermatology.

 For further information: 

EMAIL:  info@sterispharma.com  / contact@sterispharma.com   

CALL/WHATSAPP: 7877551268, 7849827488

BUY NOW